Finnish Cancer Center

FICAN
/
FICAN South
/
Projects
/
FICAN South Project Funding

FICAN South Project Funding

We annually launch a project call for development activities aligned with the priority areas of FICAN South’s goals. The project call is targeted at the parties to the FICAN South agreement (HUS, University of Helsinki, South Karelia Wellbeing Services County, Kymenlaakso Wellbeing Services County, Päijät-Häme Wellbeing Services County), whose tasks are related to cancer prevention, diagnosis, treatment or rehabilitation, cancer research, and/or cancer-related education. Projects must include participants from at least two of the FICAN South agreement parties.

FICAN South Funds the Following Clinical Projects in 2025

  • Improving treatment outcomes in cancer patients with thromboprophylaxis: Apixaban versus standard treatment during neoadjuvant chemotherapy for bladder cancer patients and after urological, abdominal and gynecological cancer surgeries – randomized ACB and ARTS studies
    Principal investigator: Professor Kari Tikkinen, Faculty of Medicine, University of Helsinki; HUS Abdominal Center, Department of Urology
  • Can extensive real-world data analysis offer novel tools to guide the treatment of HER2-positive, metastatic breast cancer?
    Principal investigator: Research director, professor Peeter Karihtala, Comprehensive Cancer Center HUS and Faculty of Medicine, University of Helsinki
  • Personalized Diagnostics in High-grade Serous Carcinoma
    Principal investigator: Academy Research Fellow, MD Anni Virtanen, HUS Diagnostic Center and Faculty of Medicine, Research Program Systems Oncology, University of Helsinki
  • PErsonalized TReatment for Endometrial Carcinoma (PETREC)
    Principal investigator: Chief physician, Adjunct professor Mikko Loukovaara, HUS Gynecology and Obstetrics & HUS Comprehensive Cancer Center
  • PROtective ileoStomy versus ProtectivE colostomy in anterior Rectal resectIon – a multicenter, open-label, randomized conTrolled studY (PROSPERITY)
    Principal investigator: Adjunct professor, Dr. Laura Koskenvuo, HUS Abdominal Center
  • Development and implementation of digital treatment paths for cancer patients on a digital platform in cooperation with the wellbeing services counties of South Karelia, Kymenlaakso and Päijät-Häme
    Project Manager: Chief physician Mari Metso-Lintula, Wellbeing services county of South Karelia
  • Developing an integrated molecular tumor board (iMTB) reporting system for cancer precision medicine
    Project Manager: Adjunct professor Vilja Pietiäinen, Institute for Molecular Medicine Finland/ HiLIFE, University of Helsinki
  • Clinical trial LD-VenEx oral outpatient treatment for acute myeloid leukemia
    Principal investigator:  Adjunct professor Dr. Mika Kontro, Comprehensive Cancer Center, HUS